Hypothyroidism is common because multiple widespread factors converge on one small gland. Autoimmune disease, aging, iodine imbalances, environmental chemicals, and even medical treatments for other thyroid conditions all independently drive up the numbers. Worldwide prevalence ranges from 0.3% to 12% depending on the population studied and local iodine intake, making it one of the most frequent endocrine disorders on the planet.
Autoimmune Disease Is the Leading Cause
In countries with adequate iodine in the food supply (including the U.S., Canada, and most of Europe), the dominant cause of hypothyroidism is Hashimoto’s thyroiditis. In this condition, the immune system gradually attacks the thyroid gland, destroying the tissue that produces thyroid hormones. Because the damage accumulates slowly, many people live with Hashimoto’s for years before their hormone levels drop enough to cause symptoms.
Why autoimmune thyroid disease is so prevalent in the first place is a harder question. Genetics play a clear role: it runs in families and is far more common in women, likely due to immune-related genes on the X chromosome. But genetics alone don’t explain the high rates. Animal research supports what’s known as the hygiene hypothesis, the idea that modern sanitation and fewer childhood infections leave the immune system more prone to attacking the body’s own tissues. In mouse models of autoimmune thyroid disease, exposure to certain parasites and bacteria suppressed the immune response that triggers the condition, suggesting that the cleaner environments of industrialized nations may paradoxically contribute to higher rates.
Women and Older Adults Are Hit Hardest
Hypothyroidism is significantly more common in women than men, a pattern seen across virtually every population studied. The gap is driven largely by the higher rates of autoimmune disease in women, though hormonal fluctuations during pregnancy and menopause also stress the thyroid in ways that can tip it into underperformance.
Age is the other major demographic driver. As people get older, TSH (the hormone that tells the thyroid to work harder) naturally rises. Data from the National Health and Nutrition Examination Survey found that the upper boundary of normal TSH exceeded 7.0 mIU/L in people over 80, compared to much lower cutoffs in younger adults. The normal range also widens with age. This shift means that some degree of thyroid slowing is a normal part of aging, not necessarily a disease. One analysis of the same data estimated that 70% of older adults whose TSH exceeded standard lab reference ranges actually fell within normal limits for their age group. In other words, a significant chunk of hypothyroidism diagnoses in older people may reflect age-appropriate thyroid function being measured against younger benchmarks.
The Iodine Paradox
Iodine is the essential raw material the thyroid needs to build its hormones. Too little iodine remains the leading cause of hypothyroidism globally, particularly in parts of Africa, South Asia, and Southeast Asia where iodized salt programs are incomplete. Severe deficiency causes goiter (an enlarged thyroid) and, during pregnancy, can deprive a developing fetus of the hormones needed for brain development.
The counterintuitive part is that too much iodine also causes problems. When the thyroid is suddenly flooded with iodine, it temporarily shuts down hormone production as a protective measure. In most people this resolves on its own, but in those with underlying autoimmune thyroid conditions or existing thyroid nodules, the shutdown can become permanent. This means that countries which successfully introduced iodine fortification programs sometimes see a rise in autoimmune hypothyroidism even as they eliminate deficiency-related cases. It’s a tradeoff: fewer goiters and fewer developmental problems in children, but more autoimmune thyroid disease in susceptible adults.
Environmental Chemicals That Target the Thyroid
The thyroid is unusually vulnerable to industrial chemicals because its hormone-production process has several steps that can be disrupted from outside the body. A growing list of common environmental contaminants interferes with thyroid function through different mechanisms.
- BPA (bisphenol A), found in plastics and food container linings, is structurally similar enough to thyroid hormones that it competes with them for receptor binding. It reduces levels of the active thyroid hormones T3 and T4, and it interferes with the enzymes that convert one form of thyroid hormone into another.
- Perchlorate, a contaminant in drinking water and a byproduct of certain industrial processes, blocks the channel the thyroid uses to absorb iodine. It’s roughly 20 times more potent at this than thiocyanate (found in cigarette smoke) and over 500 times more potent than nitrate.
- PFAS (per- and polyfluoroalkyl substances), the so-called “forever chemicals” used in nonstick coatings and water-resistant fabrics, inhibit the enzyme the thyroid needs to build its hormones and also disrupt iodine uptake. Roughly 4,000 of these compounds are currently in production, and they accumulate in the body over time.
- Flame retardants (PBDEs) and phthalates alter the activity of enzymes that activate or deactivate thyroid hormones in tissues throughout the body.
Exposure to these chemicals is essentially universal in industrialized countries. Most people carry detectable levels of several of them at any given time. No single chemical at typical environmental levels is likely to cause overt hypothyroidism on its own, but the cumulative burden of multiple compounds acting on different parts of the same system may help explain why thyroid dysfunction is more common than the genetics alone would predict.
Medical Treatments Create New Cases
A meaningful share of hypothyroidism cases are iatrogenic, meaning they’re caused by treatment for a different thyroid problem. Radioactive iodine therapy, the standard treatment for Graves’ disease (the most common form of hyperthyroidism), destroys thyroid tissue to bring hormone levels down. With current dosing, up to 80% of patients who undergo this treatment develop permanent hypothyroidism afterward, most within the first six months. Surgical removal of the thyroid for cancer or large goiters has a similar outcome. These patients then require lifelong thyroid hormone replacement.
This creates a ratchet effect in the population: people who once had overactive thyroids join the pool of people with underactive thyroids, and they stay there permanently. As detection and treatment of hyperthyroidism and thyroid cancer have improved over the decades, this pathway has steadily added to overall hypothyroidism numbers.
Broader Testing and Lower Thresholds
Part of the answer to “why is hypothyroidism so common” is simply that we look for it more systematically than we used to. TSH testing is now routine in primary care, particularly for women and older adults. U.S. data from commercially insured adults shows a consistent rate of about 12 TSH tests per 1,000 person-months, with higher rates among women and people over 55.
The definition of “abnormal” also matters enormously. Standard lab reference ranges typically flag any TSH above about 4.5 mIU/L. Treatment guidelines recommend medication for persistent TSH at or above 10 mIU/L, but the large gray zone between 4.5 and 10 is where millions of people receive a diagnosis of subclinical hypothyroidism. Whether that label helps or harms is genuinely debated, particularly in older adults whose naturally higher TSH may be completely appropriate for their age. A mildly elevated TSH in a 75-year-old is not the same clinical finding as the same number in a 30-year-old, yet the same reference range is often applied to both.
This doesn’t mean hypothyroidism is being overdiagnosed across the board. Plenty of people with genuine, symptomatic hypothyroidism benefit from treatment. But the combination of widespread testing and age-blind reference ranges does inflate the apparent prevalence, especially in aging populations.